Skip to main content
SpringerLink
Log in

The evidence for adjuvant treatment of elderly patients (age ≥ 70) with stage III colon cancer is inconclusive

  • Short Communication
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

This article critically discusses the current evidence for adjuvant chemotherapy in elderly patients (≥70 years of age) with stage III colon cancer. The authors emphasize that current evidence is inconclusive, and surgeons should be aware of this fact when making informed decisions and recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mano MS, Duhoux F. Colon cancer: update on adjuvant therapy. Clin Colorectal Cancer 2008;7(3):178–183.

    Article  CAS  PubMed  Google Scholar 

  2. Muss HB, Biganzoli L, Sargent DJ, Aapro M. Adjuvant therapy in the elderly: making the right decision. J Clin Oncol 2007; 25(14):1870–1875.

    Article  PubMed  Google Scholar 

  3. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;345(15):1091–1097.

    Article  CAS  PubMed  Google Scholar 

  4. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345(8955):939–944.

    Article  Google Scholar 

  5. Zaniboni A, Labianca R, Marsoni S, Torri V, Mosconi P, Grilli R, et al. GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma—long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon. Cancer 1998;82(11):2135–2144.

    Article  CAS  PubMed  Google Scholar 

  6. O’Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, et al. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 1998;16(1):295–300.

    PubMed  Google Scholar 

  7. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 1989;7(10):1447–1456.

    CAS  PubMed  Google Scholar 

  8. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 1994;106(4): 899–906.

    CAS  PubMed  Google Scholar 

  9. Arora A, Potter J. Older patients with colon cancer: is adjuvant chemotherapy safe and effective? J Am Geriatr Soc 2003;51(4): 567–569.

    Article  Google Scholar 

  10. Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol 2006;24(15): 2368–2375.

    Article  CAS  PubMed  Google Scholar 

  11. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002;20(19): 3992–3998.

    Article  CAS  PubMed  Google Scholar 

  12. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005;294(21):2703–2711.

    Article  CAS  PubMed  Google Scholar 

  13. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002;136(5):349–357.

    CAS  PubMed  Google Scholar 

  14. Retornaz F, Monette J, Batist G, Monette M, Sourial N, Small D, et al. Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot study. J Gerontol 2008;63(5):518–522.

    Google Scholar 

  15. Hata F, Sasaki K, Hirata K, Yamamitsu S, Shirasaka T. Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: a prospective randomized trial. Surg Today 2008;38(7):623–632.

    Article  CAS  PubMed  Google Scholar 

  16. Koh PK, Seow-Choen F. Multicentre prospective randomized trials are not always relevant to surgeons. Aust NZ J Surg 2006;76(5):286–287.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Alexandra Hospital, Singapore, Singapore

    Kok-Yang Tan

  2. Department of Surgery, Saitama Medical Center, Jichi Medical University, 1-847 Amanumacho, Omiya-ku, Saitama, 330-8503, Japan

    Kok-Yang Tan, Fumio Konishi & Koichi Suzuki

Authors
  1. Kok-Yang Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fumio Konishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Koichi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, KY., Konishi, F. & Suzuki, K. The evidence for adjuvant treatment of elderly patients (age ≥ 70) with stage III colon cancer is inconclusive. Surg Today 40, 385–387 (2010). https://doi.org/10.1007/s00595-009-4047-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-009-4047-0

Key words

Search

Navigation